Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbal Medicine for HBV-Related Acute-on-Chronic Liver Failure
NCT03577938Completed
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Elix Cycle Balance in acute-on-chronic liver failure (ACLF) (2 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoint: Transplant-free survival at 12 weeks. Started Jan 2019; status: completed.
02
Drugs
Elix Cycle Balance
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT03577938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03577938.